Your browser doesn't support javascript.
loading
Use of fluoroquinolones for the treatment of TB: 8 years of experience.
Ferrand, H; Blanc-Gruyelle, A-L; Amsilli, M; Lemaire, X; Papot, E; Papy, E; Bervar, J; Senneville, E; Bouvet, E; Yazdanpanah, Y.
Afiliação
  • Ferrand H; Service de Maladies Infectieuses, Hôpital Bichat, Paris, France Helene.Ferrand@ch-libourne.fr.
  • Blanc-Gruyelle AL; Médecine Polyvalente et Maladies Infectieuses, Centre Hospitalier de Douai, Douai, France.
  • Amsilli M; Service de Maladies Infectieuses, Hôpital Bichat, Paris, France.
  • Lemaire X; Médecine Polyvalente et Maladies Infectieuses, Centre Hospitalier de Douai, Douai, France.
  • Papot E; Service de Maladies Infectieuses, Hôpital Bichat, Paris, France.
  • Papy E; Pharmacie, Hôpital Bichat, Paris, France.
  • Bervar J; Service de Pneumologie, Hôpital Calmette, Lille, France.
  • Senneville E; Service de Maladies Infectieuses, Hôpital Dron, Tourcoing, France.
  • Bouvet E; Service de Maladies Infectieuses, Hôpital Bichat, Paris, France.
  • Yazdanpanah Y; Service de Maladies Infectieuses, Hôpital Bichat, Paris, France.
J Antimicrob Chemother ; 70(11): 3166-7, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26260132

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Fluoroquinolonas / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Fluoroquinolonas / Antituberculosos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article